JP Morgan Maintains Neutral on Molecular Partners, Lowers Price Target to $4.5
BenzingaDec 5, 2023 10:48 ET
Molecular Partners Analyst Ratings
BenzingaDec 5, 2023 10:46 ET
SVB Leerink Downgrades Molecular Partners to Market Perform, Lowers Price Target to $8
Benzinga Real-time NewsAug 29, 2022 04:44 ET
Molecular Partners Analyst Ratings
Benzinga Analyst RatingsAug 29, 2022 04:42 ET
Credit Suisse Cuts Price Target on Molecular Partners to CHF6 From CHF8, Lowers Probability of Success for Ensovibep to 5%, Keeps Neutral Rating
MT NewswiresJul 21, 2022 13:03 ET
No Data
No Data